CA2082811A1 - Utilisation du 5,10-methylene-tetrahydrofolate comme modulateur d'un agent chimiotherapeutique - Google Patents
Utilisation du 5,10-methylene-tetrahydrofolate comme modulateur d'un agent chimiotherapeutiqueInfo
- Publication number
- CA2082811A1 CA2082811A1 CA002082811A CA2082811A CA2082811A1 CA 2082811 A1 CA2082811 A1 CA 2082811A1 CA 002082811 A CA002082811 A CA 002082811A CA 2082811 A CA2082811 A CA 2082811A CA 2082811 A1 CA2082811 A1 CA 2082811A1
- Authority
- CA
- Canada
- Prior art keywords
- tetrahydrofolate
- methylene
- modulator
- chemotherapeutic agent
- ch2fh4
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- QYNUQALWYRSVHF-OLZOCXBDSA-N (6R)-5,10-methylenetetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1C1)N)N1C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QYNUQALWYRSVHF-OLZOCXBDSA-N 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 229940127089 cytotoxic agent Drugs 0.000 title 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 abstract 1
- -1 compound 5,10-methylene-tetrahydrofolate Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960002949 fluorouracil Drugs 0.000 abstract 1
- 230000005917 in vivo anti-tumor Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52171290A | 1990-05-11 | 1990-05-11 | |
| US521,712 | 1990-05-11 | ||
| PCT/US1991/003186 WO1991017660A1 (fr) | 1990-05-11 | 1991-05-13 | 5,10-methylene-tetrahydrofolate comme modulateur d'un agent chimiotherapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2082811A1 true CA2082811A1 (fr) | 1991-11-12 |
| CA2082811C CA2082811C (fr) | 2004-11-16 |
Family
ID=24077829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002082811A Expired - Lifetime CA2082811C (fr) | 1990-05-11 | 1991-05-13 | Utilisation du 5,10-methylene-tetrahydrofolate comme modulateur d'un agent chimiotherapeutique |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU7953291A (fr) |
| CA (1) | CA2082811C (fr) |
| WO (1) | WO1991017660A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH684644A5 (de) | 1992-07-13 | 1994-11-15 | Eprova Ag | 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen. |
| US5719132A (en) * | 1996-06-27 | 1998-02-17 | Bristol-Myers Squibb Company | Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil |
| CH693255A5 (de) * | 1997-06-13 | 2003-05-15 | Eprova Ag | Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels. |
| SE0303526D0 (sv) * | 2003-12-22 | 2003-12-22 | Biofol Ab | Chemotherapeutic agents |
| EP2617421A1 (fr) * | 2012-01-20 | 2013-07-24 | Isofol Medical AB | Tétrahydrofolates en combinaison avec les inhibiteurs EGFR dans l'utilisation pour le traitement du cancer |
-
1991
- 1991-05-13 CA CA002082811A patent/CA2082811C/fr not_active Expired - Lifetime
- 1991-05-13 AU AU79532/91A patent/AU7953291A/en not_active Abandoned
- 1991-05-13 WO PCT/US1991/003186 patent/WO1991017660A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1991017660A1 (fr) | 1991-11-28 |
| CA2082811C (fr) | 2004-11-16 |
| AU7953291A (en) | 1991-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2111527A1 (fr) | Phosphonooxymethylethers de derives du taxane | |
| CA2129288A1 (fr) | Esters phosphonooxymethyliques de derives de taxane | |
| CA2016659A1 (fr) | Compose stabilise contenant un facteur de croissance epidermique | |
| UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
| CA2163706A1 (fr) | Derives amino-acides de paclitaxel | |
| CA2182582A1 (fr) | Compositions contenant du nebivolol micronise | |
| CA2125895A1 (fr) | Coordinats renfermant des heteroatomes; complexes metalliques de ces coordinats | |
| CA2182200A1 (fr) | Formulations s'appliquant au facteur ix | |
| GEP20022709B (en) | Pharmaceutical Compositions Having Appetite Suppressant Activity | |
| CA2091360A1 (fr) | Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques | |
| CA2124677A1 (fr) | Agents immunopotentialisateurs et leurs sels physiologiquement compatibles | |
| CA2110693A1 (fr) | Derive d'acide amine anticonvulsif | |
| CS653586A3 (en) | Pharmaceutical containing 7-isopropoxyisoflavone | |
| GEP20002331B (en) | Alkylated Raphamicine Derivatives | |
| CA2150251A1 (fr) | Lyospheres contenant de la gonadotropine | |
| CA2163361A1 (fr) | Derives de substitution de guanidines, agents therapeutiques | |
| MY101784A (en) | Novel pharmacological compounds | |
| CA2163837A1 (fr) | Hydrates de paclitaxel cristallises | |
| CA2114136A1 (fr) | Complexes de gallium (iii), procede de production et compositions pharmaceutiques en contenant | |
| CA2152771A1 (fr) | Derives 7-o-ether de taxane | |
| CA2217710A1 (fr) | Substance anticancereuse inhibant les metastases cancereuses | |
| PH31395A (en) | Bis-naphthalimides for the treatment of cancer. | |
| CA2082811A1 (fr) | Utilisation du 5,10-methylene-tetrahydrofolate comme modulateur d'un agent chimiotherapeutique | |
| CA2114859A1 (fr) | Compose cytotoxique et antiviral | |
| IL110780A0 (en) | Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |